SCHEMBL18856260

SCHEMBL18856260

C=Nc1ccc(C#N)c(C(F)(F)F)c1

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 19/20 0.51
▸ PGR P06401 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4404032 0.82 AR (0.51) ARPGR
SCHEMBL4402110 0.82 AR (0.51) ARPGR
SCHEMBL16130164 0.81 AR (0.50) ARPGR
SCHEMBL189787 0.79 AR (0.49) ARPGR
SCHEMBL1190703 0.79 AR (0.49) ARPGR
SCHEMBL22834021 0.78 AR (0.47) ARPGR
SCHEMBL21936494 0.78 AR (0.47) ARPGR
SCHEMBL12960442 0.76 AR (0.45) ARPGR
SCHEMBL9288540 0.76 AR (0.56) ARPGR
SCHEMBL16950996 0.76 AR (0.56) ARPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021150603-A1 ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2021-07-29 — — WO disclosed
WO-2017081702-A2 A PROCESS FOR PREPARATION OF ENZALUTAMIDE SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2017-05-18 — — WO disclosed
Send feedback